MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an announcement. On November 20, 2025, MAIA Biotechnology announced that its CEO, Vlad Vitoc, ...

Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

The Southeast Asian Regional Center for Graduate Study and Research in Agriculture (Searca) participated in the recent ...

Researchers from CIIMAR and the University of Helsinki have discovered a new biochemical modification in natural ...

An international team of scientists has found compelling evidence that early-infancy infection with respiratory syncytial ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS’ ...

Company starts enrollment in Romania for Phase 2 THIO-101 Part C study of ateganosine as a treatment for advanced non-small ...

China's control over critical supply chains threatens U.S. national security in artificial intelligence, quantum computing ...

Fever slows seasonal flu by blocking viral replication, but bird-flu strains resist heat. New research reveals why—and what ...